HKU Scholars Hub: Browsing DSpace

Browsing by Author Hann, HW

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 4 to 11 of 11 < previous

	Title	Author(s)	Issue Date
	Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir Journal:Hepatology	Leung, N Peng, CY Hann, HW Sollano, J LaoTan, J Hsu, CW Lesmana, L Yuen, MF Jeffers, L Sherman, M Min, A Mencarini, K Diva, U Cross, A Wilber, R LopezTalavera, J	2009
	Entecavir (ETV) Results in Higher HBV-DNA Reduction vs Adefovir (ADV) In Chronically Infected HBeAg(+) Antiviral-Naive Adults: 48-Week Results (E.A.R.L.Y. STUDY) Proceeding/Conference:Digestive Disease Week	Leung, N Sherman, M Peng, CY Sollano, JD Lesmana, L Yuen, RMF Jeffers, L Hann, HW Menearini, K Colonno, R Cross, A Wilber, R Lopez-Talavera, JC	2007
	Entecavir (ETV) therapy in chronic hepatitis B patients previously treated with adefovir (ADV) with incomplete response on-treatment or relapse off-treatment Proceeding/Conference:Journal of Hepatology	Lai, CL Elion, R Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mercarni, K Zhang, H Iloeje, UH Kreter, B	2009
	Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment Proceeding/Conference:Gastroenterology	Lai, CL Elion, RA Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mencarini, KA Zhang, H Iloeje, UH Kreter, B	2009
	Entecavir (ETV) vs. Adefovir (ADV): HBV DNA reduction of viral load in chronically infected HBeAg(+) nucleoside naive adults in a 12-week Proceeding/Conference:Journal of clinical virology	Sherman, M Hann, HW Jeffers, L Min, A Leung, N Peng, CY Liaw, YF Sollano, J Lesmana, L Yuen, RMF Zhu, J Mencarini, K Colonno, R Cross, A Wilber, R Lopez-Talavera, JC	2006
	Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology	Ma, XL Lalezari, J Nguyuen, T Bae, Ho Schiff, ER Fung, S Yuen, RMF Hassanein, T Hann, HW Elkhashab, M Dieterich, D Sulkowski, M Kwo, P Nahass, R Agarwal, K Ramji, A Park, J Ravendhran, N Chan, S Weilert, F Han, SH Ayoub, W Gane, E Jacobson, I Bennett, M Huang, Q Yan, R Huey, V Ruby, E Liaw, S Colonno, R Lopatin, U	2019
	Results of a One-year International Phase IIB Comparative Trial of Telbivudine, Lamivudine, and the Combination, in Patients with Chronic Hepatitis B Proceeding/Conference:Hepatology	Lai, CL Leung, NWY Teo, EK Tong, M Wong, F Hann, HW Han, S Poynard, T Myers, M Chao, G Lloyd, D Brown, N	2003
	Viral response and safety following discontinuation of treatment with the core inhibitor vebicorvir and a nucleos (t)ide reverse transcriptase inhibitor in patients with HBeAg positive or negative chronic hepatitis B virus infection Proceeding/Conference:Journal of Hepatology	Gane, E SulkowskI, M Ma, X Nguyen, T Hann, HW Hassanein, T Elkhashab, M Chan, S Nahass, R Bennett, M Park, J Jacobson, I Bonacini, M Ma, J Yan, R Knox, SJ Stamm, L Ramji, A Han, SHB Ayoub, W Ravendhran, N Kwo, PY Dieterich, D Bae, H Schiff, ER Lalezari, J Fung, S Yuen, RMF	2021

Showing results 4 to 11 of 11 < previous